Company / Net Debt per Share
Idexx Laboratories Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$3.31
FY2025
5-year range
$2.95 / $8.27
FY2021-FY2025
Trend
-16.7%
vs FY2024
Sector context
#64 of 100
Health Care
What the data says
At $3.31, Idexx Laboratories's net debt per share ranks #37 of 100 in the Health Care sector. Net Debt per Share has fluctuated over the past 10 years, ranging from $2.95 in FY2023 to $8.27 in FY2021.
Based on SEC 10-K filings.
3.31 in FY2025 with a 5-year CAGR of -11.6%.
Increased from $2.95 to $3.31 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -24.8%
- 5-Year CAGR
- -11.6%
- 10-Year CAGR
- -
Sector benchmark
#37 of 100 in Health CareTop 36% of 100This company $3.31 Sector average $7.63
▼
-56.6% below sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 16.7% year-over-year.
- Ranks #64 out of 100 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2021.
- Lowest net debt per share in the period was in FY2023.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.31 | -16.7% |
| FY2024 | $3.97 | +34.7% |
| FY2023 | $2.95 | -62.1% |
| FY2022 | $7.77 | -6.0% |
| FY2021 | $8.27 | +34.5% |
| FY2020 | $6.14 | -13.1% |
| FY2019 | $7.07 | +28.9% |
| FY2018 | $5.49 | +22.7% |
| FY2017 | $4.47 | +3.5% |
| FY2016 | $4.32 | -0.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026